Načítá se...
Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder
Major depressive disorder (MDD) contributes to a significant worldwide disease burden, expected to be second only to heart disease by 2050. However, accurate diagnosis has been a historical weakness in clinical psychiatry. As a result, there is a demand for diagnostic modalities with greater objecti...
Uloženo v:
| Vydáno v: | Front Psychiatry |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4843170/ https://ncbi.nlm.nih.gov/pubmed/27199779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpsyt.2016.00072 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|